Drug Profile
Nix 0699
Alternative Names: Hemoxin; Nicosan; NiprisanLatest Information Update: 13 Jul 2006
Price :
$50
*
At a glance
- Originator National Institute for Pharmaceutical Research and Development
- Class Antianaemics; Phytotherapies
- Mechanism of Action Haemoglobin modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Sickle cell anaemia
Most Recent Events
- 06 Jul 2006 First global launch of Nix 0699 [Nigeria]
- 06 Jul 2006 Launched for Sickle cell anaemia in Nigeria (PO)
- 03 Jul 2006 Registered for Sickle cell anaemia in Nigeria (PO)